517 related articles for article (PubMed ID: 19767623)
1. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
[TBL] [Abstract][Full Text] [Related]
3. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
Yong C; Fisher DA; Sklar GE; Li SC
Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
[TBL] [Abstract][Full Text] [Related]
4. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.
Barr DA; Semple L; Seaton RA
Int J Antimicrob Agents; 2012 May; 39(5):407-13. PubMed ID: 22445493
[TBL] [Abstract][Full Text] [Related]
5. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
Dimitrova M; Gilchrist M; Seaton RA
BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
[TBL] [Abstract][Full Text] [Related]
6. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.
Partridge DG; O'Brien E; Chapman AL
Postgrad Med J; 2012 Jul; 88(1041):377-81. PubMed ID: 22366395
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
[TBL] [Abstract][Full Text] [Related]
8. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia.
Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG
Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999
[TBL] [Abstract][Full Text] [Related]
9. Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting.
Kieran J; O'Reilly A; Parker J; Clarke S; Bergin C
Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1369-74. PubMed ID: 19697069
[TBL] [Abstract][Full Text] [Related]
10. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
Conant MM; Erdman SM; Osterholzer D
J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
[TBL] [Abstract][Full Text] [Related]
11. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
Bhavan KP; Brown LS; Haley RW
PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
[TBL] [Abstract][Full Text] [Related]
12. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
Bazaz R; Chapman AL; Winstanley TG
J Antimicrob Chemother; 2010 Jul; 65(7):1510-3. PubMed ID: 20460397
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
[TBL] [Abstract][Full Text] [Related]
14. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
[TBL] [Abstract][Full Text] [Related]
15. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.
Gilchrist M; Seaton RA
J Antimicrob Chemother; 2015 Apr; 70(4):965-70. PubMed ID: 25538169
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
[TBL] [Abstract][Full Text] [Related]
17. Clinical and cost-effectiveness, safety and acceptability of
Mitchell ED; Czoski Murray C; Meads D; Minton J; Wright J; Twiddy M
BMJ Open; 2017 Apr; 7(4):e013560. PubMed ID: 28428184
[TBL] [Abstract][Full Text] [Related]
18. Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical Unit.
Yan YM; Singh M; Tonks K; Kavi J; Langford NJ
Acute Med; 2011; 10(1):22-5. PubMed ID: 21573260
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Pediatric Outpatient Parenteral Antibiotic Therapy Implementation at a Tertiary Children's Hospital in the United Kingdom.
Patel S; Burzio V; Green H; Rees S; Tebruegge M; Jones C; Faust SN
Pediatr Infect Dis J; 2018 Dec; 37(12):e292-e297. PubMed ID: 29613971
[TBL] [Abstract][Full Text] [Related]
20. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.
Mackintosh CL; White HA; Seaton RA
J Antimicrob Chemother; 2011 Feb; 66(2):408-15. PubMed ID: 21118914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
